Drug Search Results
More Filters [+]

VVN-1901

Alternative Names: VVN-1901, VVN 1901, VVN1901
Latest Update: None
Latest Update Note: None

Product Description

Mechanisms of Action: Unknown

Novel Mechanism: No

Modality: N/A

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Weimo Biotechnology (Zhejiang) Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for VVN-1901

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 1: Keratitis

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20241891

P1

Unknown

Keratitis

None

Recent News Events

Date

Type

Title